Pauza Charles David (CIK 2018150) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-16). Recent activity: Buy TRAW (18,471 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-16 | Traws Pharma, Inc. (TRAW) | Chief Science Officer Virology | Buy | 18,471 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-16